M.A. Gentil

1.8k total citations
59 papers, 1.3k citations indexed

About

M.A. Gentil is a scholar working on Transplantation, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, M.A. Gentil has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Transplantation, 15 papers in Psychiatry and Mental health and 13 papers in Epidemiology. Recurrent topics in M.A. Gentil's work include Renal Transplantation Outcomes and Treatments (36 papers), Neurological Complications and Syndromes (13 papers) and Pharmacological Effects and Toxicity Studies (10 papers). M.A. Gentil is often cited by papers focused on Renal Transplantation Outcomes and Treatments (36 papers), Neurological Complications and Syndromes (13 papers) and Pharmacological Effects and Toxicity Studies (10 papers). M.A. Gentil collaborates with scholars based in Spain, Sweden and Belgium. M.A. Gentil's co-authors include Virginia Cabello, Elisa Cordero, José Miguel Cisneros, Gabriel Bernal, Julia Fijo, P. Pereira, G. Algarra, F.M. González-Roncero, Merçè Brunet and Henrik Ekberg and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Transplantation.

In The Last Decade

M.A. Gentil

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Gentil Spain 23 702 442 257 246 214 59 1.3k
É. Thervet France 22 812 1.2× 386 0.9× 187 0.7× 415 1.7× 199 0.9× 47 1.5k
Núria Esforzado Spain 19 465 0.7× 601 1.4× 335 1.3× 208 0.8× 99 0.5× 76 1.2k
Philippe Gatault France 19 528 0.8× 258 0.6× 65 0.3× 283 1.2× 236 1.1× 91 1.2k
Bekir Tanrıöver United States 20 810 1.2× 200 0.5× 199 0.8× 594 2.4× 302 1.4× 69 1.4k
Britta Höcker Germany 20 503 0.7× 220 0.5× 63 0.2× 277 1.1× 161 0.8× 54 934
Abdolreza Haririan United States 28 1.1k 1.5× 450 1.0× 105 0.4× 620 2.5× 372 1.7× 84 2.2k
Michelle Lubetzky United States 20 626 0.9× 259 0.6× 92 0.4× 355 1.4× 183 0.9× 45 1.3k
Laurence Lavayssière France 24 831 1.2× 627 1.4× 842 3.3× 657 2.7× 302 1.4× 69 2.0k
M.J. Ricart Spain 23 548 0.8× 791 1.8× 78 0.3× 514 2.1× 85 0.4× 77 1.5k
Ilkka Helanterä Finland 21 448 0.6× 605 1.4× 67 0.3× 314 1.3× 131 0.6× 94 1.3k

Countries citing papers authored by M.A. Gentil

Since Specialization
Citations

This map shows the geographic impact of M.A. Gentil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Gentil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Gentil more than expected).

Fields of papers citing papers by M.A. Gentil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Gentil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Gentil. The network helps show where M.A. Gentil may publish in the future.

Co-authorship network of co-authors of M.A. Gentil

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Gentil. A scholar is included among the top collaborators of M.A. Gentil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Gentil. M.A. Gentil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blanco-Lobo, Pilar, Elisa Cordero, Cecilia Martín‐Gandul, et al.. (2016). Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation. Journal of Infection. 72(5). 597–607. 18 indexed citations
2.
Gentil, M.A., Manel Perelló, Sofía Zárraga, et al.. (2016). Hepatitis C Treatment With Direct-Acting Antivirals in Kidney Transplant: Preliminary Results From a Multicenter Study. Transplantation Proceedings. 48(9). 2944–2946. 17 indexed citations
3.
Gentil, M.A., et al.. (2015). Survival of Kidney Allograft of Donors after Circulatory Death Is Similar to Donors after Brain Death: Experience in a Regional Program. Transplantation Proceedings. 47(9). 2572–2574. 5 indexed citations
4.
Martín‐Gandul, Cecilia, Pilar Pérez‐Romero, Pilar Blanco-Lobo, et al.. (2014). Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy. Transplant International. 27(10). 1060–1068. 24 indexed citations
5.
Arias, M., Domingo Hernández, Lluís Guirado, et al.. (2013). Clinical profile and post-transplant anaemia in renal transplant recipients restarting dialysis after a failed graft: changing trends between 2001 and 2009. Clinical Kidney Journal. 6(2). 156–163.
6.
Llaudó, Inés, Helena Colom, Pepita Gimenez‐Bonafé, et al.. (2012). Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study. Transplant International. 26(2). 177–186. 31 indexed citations
7.
Guirado, Luís, C. Cantarell, Antonio Franco, et al.. (2011). Efficacy and Safety of Conversion from Twice-daily to Once-daily Tacrolimus in a Large Cohort of Stable Kidney Transplant Recipients. American Journal of Transplantation. 11(9). 1965–1971. 66 indexed citations
8.
Gentil, M.A., et al.. (2009). Regional Survey of Patient Survival After Cadaver Renal Transplant Failure. Transplantation Proceedings. 41(6). 2089–2091. 2 indexed citations
9.
Gentil, M.A., Miguel Ángel Pérez Valdivia, Manuel López Mendoza, et al.. (2008). Factor Deficiency in the Anemia of Renal Transplant Patients With Grade III–IV Chronic Kidney Disease: Baseline Results of the ARES Study. Transplantation Proceedings. 40(9). 2922–2924. 9 indexed citations
10.
Aguilera, Isabel, et al.. (2008). Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients. Nephrology Dialysis Transplantation. 23(7). 2393–2398. 26 indexed citations
11.
Cabello, Virginia, et al.. (2008). Treatment of BK Virus–Associated Nephropathy With Cidofovir in Renal Transplantation. Transplantation Proceedings. 40(9). 2930–2932. 13 indexed citations
12.
Grinyó, Josep M., Henrik Ekberg, Federico Oppenheimer, et al.. (2007). Pharmacokinetics of total and free mycophenolic acid in renal transplantation receiving standard-dose cyclosporine, low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: The symphony PK sub-study. Transplant International. 20. 177–177. 4 indexed citations
13.
Aguilera, Isabel, et al.. (2005). Alloimmune Response Against Donor Glutathione S-Transferase T1 Antigen in Renal Transplant Recipients. American Journal of Kidney Diseases. 46(2). 345–350. 8 indexed citations
14.
Gentil, M.A., Raquel García Sevila, Miguel Ángel Pérez Valdivia, et al.. (2005). Alendronate in Kidney Transplant Patients: A Single-Center Experience. Transplantation Proceedings. 37(3). 1471–1472. 8 indexed citations
15.
Aguilera, Isabel, et al.. (2005). Antibodies Against the Donor Antigen Glutathione S-Transferase T1 After Renal Transplantation. Transplantation Proceedings. 37(3). 1457–1458. 4 indexed citations
16.
Gentil, M.A.. (2004). Impact of the new drugs in the cost of maintenance immunosuppression of renal transplantation. Is it justified?. Nephrology Dialysis Transplantation. 19(suppl_3). iii77–iii82. 7 indexed citations
17.
Bernabéu-Wittel, Máximo, José Miguel Cisneros, E Cañas, et al.. (2004). Quantitative pp65 antigenemia in the diagnosis of cytomegalovirus disease: prospective assessment in a cohort of solid organ transplant recipients. Journal of Infection. 51(3). 188–194. 16 indexed citations
18.
Gentil, M.A., et al.. (2003). Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols. Transplantation Proceedings. 35(5). 1748–1750. 13 indexed citations
19.
Gentil, M.A.. (2002). Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrology Dialysis Transplantation. 17(5). 887–891. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by É. Thervet Breakdown of academic impact, for papers by Núria Esforzado Breakdown of academic impact, for papers by Philippe Gatault Breakdown of academic impact, for papers by Bekir Tanrıöver Breakdown of academic impact, for papers by Britta Höcker Breakdown of academic impact, for papers by Abdolreza Haririan Breakdown of academic impact, for papers by Michelle Lubetzky Breakdown of academic impact, for papers by Laurence Lavayssière Breakdown of academic impact, for papers by M.J. Ricart Breakdown of academic impact, for papers by Ilkka Helanterä
Rankless by CCL
2026